The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Topic summary

Substitution between formats during a shortage — what changed since

This is a generated summary. It shows the 5 most-liked posts from a topic of 22, in their original order, with the accepted answer included where one exists. It is a reading aid and it will miss nuance — the full topic is the record.
CO
c.okaforTL3Regular Solution7 Jul 2026#3
s.beaulieu, post #1: Substitution between formats during a shortage — what changed since — setting out what I have, and where I think it stops being reliable. A coverage question with the paperwork detail included, since that is what determines the answer. Denial received, with a stated reason. My reading of the reason is that it tells me exactly what to… Go to post

Dose hold versus tapering: if a temporary shortage forces a gap, holding your dose and resuming when supply returns is different from gradually tapering. The two are different decisions.

28 likes in reply to #1 20d
CV
c.vasquezTL2 Moderator11 Jul 2026#8

International supply chains: a shortage in one country does not mean shortage in another. That is why ordering from multiple suppliers before a shortage gets bad is prudent if you can.

20 likes 17d
IA
i.almeidaTL2 Moderator12 Jul 2026#10

For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.

29 likes 15d
VB
v.bruunTL2 Moderator13 Jul 2026#11

Compounding during shortages: some jurisdictions allow pharmacy compounding when a marketed product is in shortage. That permission is jurisdiction-specific and time-limited (usually for the duration of the shortage).

30 likes 15d
OL
o.lindgrenTL2Regular18 Jul 2026#20

I read post #18 twice before replying, because I had assumed the opposite.

Dose hold versus tapering: if a temporary shortage forces a gap, holding your dose and resuming when supply returns is different from gradually tapering. The two are different decisions.

31 likes 10d

Read the full topic (22 posts)

Suggested topics

TopicParticipantsRepliesViewsActivity
How shortages have affected compounding permissions
How shortages have affected compounding permissions I have a specific reason for asking rather than idle curiosity, and the context is below. A coverage question with the paperwork detail included, since that…
CRLMCKTFGT+61 71 3.6k 2d
How shortages have affected compounding permissions — does this still hold?
How shortages have affected compounding permissions — does this still hold? — that is the question, and I have not found it answered plainly anywhere I have looked. A coverage question with the paperwork…
BVYRVKSSAS+27 31 21k 17h
Second pass at: Hoarding and why it makes a shortage worse
Second pass at: Hoarding and why it makes a shortage worse Writing it up because I had to work it out twice and would rather nobody else did. Documenting an access outcome, dated, because everything in this…
GTECKHCNTV+115 133 11k 21mo
Coming back to: Official shortage notices and what they authorise
Official shortage notices and what they authorise Writing it up because I had to work it out twice and would rather nobody else did. A coverage question with the paperwork detail included, since that is what…
SPVBAKTWFA+85 92 5.5k 11mo
Coming back to: Official shortage notices and what they authorise
Official shortage notices and what they authorise — setting out what I have, and where I think it stops being reliable. A coverage question with the paperwork detail included, since that is what determines…
DOFFAPRSRD+39 43 510 17mo

Related topics — sharing the tags shortage, formulary, FDA

TopicParticipantsRepliesViewsActivity
Tracking a shortage from primary sources rather than rumour — the long version
On the subject in the title: Tracking a shortage from primary sources rather than rumour — the long version Working notes rather than a conclusion. Documenting an access outcome, dated, because everything in…
SDLSNM 2 60 1d
Revisiting: Reading a denial letter as a specification for your appeal
Posting this under the heading it deserves: Revisiting: Reading a denial letter as a specification for your appeal Everything below is what sits behind that. A coverage question with the paperwork detail…
HAITBBPMN+125 138 9.4k 10mo
What a regulator's shortage notice actually authorises — what changed since
The question in the title: What a regulator's shortage notice actually authorises — what changed since I will give what I have already checked below so nobody repeats it. A logistics question, since the…
JMMBUCRVW+22 26 53k 7mo
Cross-border purchase rules within the EU
On the subject in the title: Cross-border purchase rules within the EU Working notes rather than a conclusion. A coverage question with the paperwork detail included, since that is what determines the answer.…
HMEFVKGZA+45 49 15k 8mo
EMA product information as a primary source
Posting this under the heading it deserves: EMA product information as a primary source Everything below is what sits behind that. Documenting an access outcome, dated, because everything in this category…
YISVCDAMB+70 74 7k 8mo